	Changes in quality of life in colorectal cancer screening: A multicentre trial in populations in China. J Med Screen Zhou XY, Li YJ, Wang H, Cai SY, Wang X, Zou SY, Du L, Liao X, Wei D, Dong D, Gao Y, Chen H, Dai M, Shi JF. PMID: 41816867 [PubMed - as supplied by publisher]
	Mechanistic Research on the Crosstalk Between Macrophage Polarization and Energy Metabolic Reprogramming in Hepatocellular Carcinoma. J Hepatocell Carcinoma Zhu R, Na J, Tan X, Chen X, Tian X, Luo J, Chen Y, Zhong L. PMID: 41816775 [PubMed]
	Evaluation of the relationship between pan-immune inflammation value and prognostic factors in germ-cell testicular cancer: analysis of stage, lymph node involvement, and metastasis. Turk J Med Sci Dinçer E, Özkaptan O, Çanakçi C, Ipek OM, Co, Sevinç AH. PMID: 41816726 [PubMed - in process]
	The effectiveness of Traditional Chinese Medicine in treating cancer related anemia: a systematic review and meta-analysis. Front Med (Lausanne) Li QY, Zhang ZY, Yang WX, Liu H, Li X, Qiu WC, Guo ZW, Shi J. PMID: 41816680 [PubMed]
	Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control. Health Sci Rep Tawe L. PMID: 41816649 [PubMed]
	Exploring individual and contextual determinants of cancer prevention behaviour change in the European Union: a qualitative study to inform implementation of the European Code Against Cancer. Lancet Reg Health Eur Feliu A, Barrera B, Boland V, Drury A, Hâncean MG, Geant, Koczkodaj P, Mulcahy-Symmons S, Pinto P, Rees VW, Sheehan S, Tchalakov I, Vu, Zeeb H, Espina C. PMID: 41816635 [PubMed]
	A hybrid molecular-imaging model for high-accuracy early colorectal cancer diagnosis. J Gastrointest Oncol Zhao Y, Zeng W. PMID: 41816600 [PubMed]
	The APOBEC3 family: a narrative review of an alternative therapeutic agent for hepatitis B virus-induced hepatocellular carcinoma. J Gastrointest Oncol Miao J, Zhang M, Ren E, Huang LT, He KF, Gao ZG. PMID: 41816598 [PubMed]
	Partial splenic embolization plus antitumor therapy for treating patients with hepatocellular carcinoma and splenomegaly: a case series study. J Gastrointest Oncol Li B, Jiang B, Pang X, Ji M. PMID: 41816597 [PubMed]
	A case report: Masson's tumor (intravascular papillary endothelial hyperplasia) of the abdominal cavity. J Gastrointest Oncol Ren Y, Yu X. PMID: 41816578 [PubMed]
	Development and internal validation of a predictive nomogram for early postoperative bacterial infections following liver transplantation in patients with hepatocellular carcinoma. J Gastrointest Oncol Cheng PF, He L, Duan BW, Zhang GM, Wu F, Wang JX, Li GM. PMID: 41816576 [PubMed]
	Identification and validation of an explainable machine learning model for early postoperative pulmonary complications after esophagectomy in patients with esophageal cancer. J Gastrointest Oncol Liu F, Wang Z. PMID: 41816575 [PubMed]
	FTSJ1-mediated IL1RN mRNA instability promotes inflammation-driven hepatocellular carcinoma. J Gastrointest Oncol Jiang S, Ding D, Zu Y, Liao Y, Wang T, Yu J, Zhou W, Yuan S. PMID: 41816574 [PubMed]
	Training and validation of a nomogram for predicting synchronous distant organ metastasis in patients with very-early-onset colorectal cancer. J Gastrointest Oncol Wen Y, Li Z, Zhang H, Huang J, Zhang Y, Ding Y, Xiao J, Zhang Y. PMID: 41816573 [PubMed]
	Cadonilimab plus chemotherapy vs. PD-1 inhibitor plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction cancer with PD-L1 combined positive score <5: a propensity-matched, retrospective cohort study. J Gastrointest Oncol Zhao D, Wu Z, Huang Y, Zhang L, Yuan X, Zhang N, Wei Q, Li J, Ying J, Xu Q. PMID: 41816572 [PubMed]
	ColoLDB: a machine learning-based predictive model for colorectal cancer using routine laboratory parameters. J Gastrointest Oncol Zhang X, Tong X, Mou J, Liu J, Zhang C, Han H, Deng K. PMID: 41816568 [PubMed]
	Clinical model for predicting overall survival outcomes in individuals with hepatocellular carcinoma: a retrospective cohort analysis. J Gastrointest Oncol Hendi M, Chen YY, Zhang B, Wang YF, Cai XJ. PMID: 41816567 [PubMed]
	DAWN trial: a prospective, multicenter, single-arm phase II study of neoadjuvant disitamab vedotin (RC48) in combination with adebrelimab, apatinib, and S-1 for locally advanced HER2-positive gastric cancer. J Gastrointest Oncol Ding Y, Qian H, Liu H, Zhang J, Zhang X, Wei J, Chen X, Xu H. PMID: 41816563 [PubMed]
	A multidisciplinary comfort-enhanced recovery after surgery program improves perioperative patient-reported outcomes after lung cancer surgery: a randomized controlled trial. J Thorac Dis Li H, Chen L, Zhou L, Zhang Q, Wang K, Yu Z, Wang W, Lin S, Jiang Y, Jiang Y. PMID: 41816488 [PubMed]
	Targeting rare oncogenic mutations in resectable non-small cell lung cancer: emerging perioperative strategies. J Thorac Dis Hao S, Zhao S, Shi L, Zhong L, Wei H, Jiao X, Xue C. PMID: 41816478 [PubMed]

Articles 1 - 20 / 1917818

Page 1 of 95891



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy